Contract Manufacturers Will Be Subject to More Inspections in U.S. and EU
This article was originally published in The Gold Sheet
Executive Summary
Contract manufacturing organizations will face more scrutiny from regulators and pharmaceutical manufacturers in the U.S. and the EU under pending supply chain initiatives. With the growing use of outsourcing, manufacturers have to be careful about who they choose as CMOs.